Clinical trials: Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
To evaluate the efficacy and safety of Cadonilimab Injection in combination with Regorafenib in the treatment of intermediate to advanced hepatocellular carcinoma that has failed at least one prior systemic therapy .
- Trial name
- NCT05644379
- Testing
- Cadonilimab Injection, Regorafenib
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital